Hiv vaccine research trials
Common Questions and Answers about Hiv vaccine research trials
hiv
Grace, I was reading through some older posts and I have seen that you stated Dr. Halford was doing some interesting research on a vaccine but it was a risky but it was using a live virus. I was wondering if you have any updates on his research? It was mentioned in a post late in 2011. I have tried to find some information online without sucess. Any ideas on the outcome of this?
Thanks in advance.
6 million ($49 million) in a European IPO, earmarking its new cash to push a hepatitis B vaccine into pivotal trials and hit the gas on an HIV drug.
Abivax has registered about 2 million shares on the Euronext Paris exchange, setting aside another roughly 300,000 for its underwriters. The biotech will be placing shares through June 22, expecting to price them at a midpoint of €21.30 ($23.91) each. If Abivax's overallotment allocation comes through, the company could gross €57.
Do you know if that research is going to continue? I believe I read that Pritelivir was in Phase II trials, so if the research started again what would be a realistic time frame for when the drug could be publicly available?
Are there any other more promising drugs in the pipeline that might be available sooner?
Another source I have been reading about is Dr William Halford (http://www.huffingtonpost.com/2015/03/03/herpes-vaccine_n_6791538.
Not sure what will happen with this as they haven't entered phase one trials yet. But I think HIV research and treatment has really been amazing thus far.
Recent trials on animals have shown it is between 85 and 100 per cent effective at blocking HIV and Herpes transmission.
4. Astellas ASP-2151
The most promising of the long-awaited Helicase Primase Inhibitors (HPI) drugs. And I really mean long-awaited. This is like super-acyclovir, and there's been some speculation that it could inhibit the virus so effectively that asymptomatic shedding may not be an issue.
5.
I'm referring to this latest news about hiv research which is also a retrovirus like hbv:
http://www.telegraph.co.uk/news/2016/10/02/hiv-cure-close-after-disease-vanishes-from-blood-of-british-man/
"The new therapy works in two stages. Firstly, a vaccine helps the body recognise the HIV-infected cells so it can clear them out. Secondly, a new drug called Vorinostat activates the dormant T-cells so they can be spotted by the immune system.
Last thing I read about it was that scientists were trying to invent a genome that would lure the virus out of its hiding place in the nerve cells. Then they would give you the anti-viral drug like acyvalvolir (don't know how to spell it) and that would kill it.
The risk is that you would face an outbreak of the virus though.
That's the only thing I heard about a cure, they're also trying to make a vaccine for it for kids but nothing successful has been made yet.
Some diseases are harder to develop a vaccine for than others. Since Coronavirus behaves, in the body, like the flu, the foundation of knowledge to develop that vaccine already exists. Also, I think most people would agree that a vaccine for a disease (Coronavirus) that is highly infectious and has killed nearly 1400 people already this year is more urgent than a vaccine for a virus that isn't deadly.
Vaccine Campaigns May Be The Cause of New AIDS-Like Disease in Asia and Drug Resistant HIV Affecting Africa
Researchers have identified mysterious new symptoms that have left scores of people in Asia and sub-Saharan Africa with an AIDS-like disease and drug-resistant HIV respectively. Coincidentally, vaccine trials took place in several regions in both continents.
The patients' immune systems become damaged, leaving them unable to fend off germs as healthy people do.
Partners and collaborators include the University of Pennsylvania, Merck, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.
For further information:
Roche Partnering
Emilie Vincent, Head of Roche Partnering Communications, emilie.
When you mention "Gileads therapeutic vaccine" did you mean its TollLike7 receptor agonist drug, that is currently in development or do they indeed also have a therapeutic vaccine in development?
The TL agonist drug was tested in Woodchucks as presented in Orlando last year and showed very impressive Vl reductions of 3 to 4 logs.
I would like to mention that an other TL7 agonist is already approved for skin conditions. Its name is Imiquimod and the brand name.
I have been battling genital warts for the last two years with minimum to no success, and ive been researching possible cures and medical research all the time.......i have now had my mind at ease that Mr Ian Frazer, the man who created the Gardisil vaccine, has been researching and developing a vaccine that not only prevents, but cures people already infected with the HPV and herpes virus!
as usual drugs that cure are not developped, today hiv researchers in rome said that hiv therapeutic vaccine works to rebuild immune system even in those with hiv und since hiv und is not equal immune system working back again normally, well after they reached phase 2 and results there is no money left......this research is all government funded no money from drugs pharma, how come?
org/
also there is a youtube video at the bottom that explains the research. They say they need donations to help complete some research studies that sound very promising. Can medhelp, help to get this information out to the public so maybe we can get more recognition and more donations ? do you think we could see a cure in maybe 5 years ?
Recommended
